Encephalitis: Clinical Trials

20 trials for Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed. 20 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 120Completed 20
Phase 24Completed 4

Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants
ART5803, Intravenous immunoglobulin (IVIG) - Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody, Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
Phase 1CompletedArialys Therapeutics72025-02-252026-04-27
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease
Phase 1 / Phase 2CompletedSK Bioscience Co., Ltd.1612025-02-242026-09-11
Phase 1 Study of ART5803 in Healthy Participants
ART5803 - Autoimmune Encephalitis
Phase 1CompletedArialys Therapeutics642024-09-192026-04-27
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
MVA-BN-WEV Dose 1, MVA-BN-WEV Dose 2, MVA-BN-WEV Dose 3 - Equine Encephalitis
Phase 1CompletedBavarian Nordic452019-10-072020-08-20
VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults
VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302019-04-022021-03-24
IL-2 in Refractory Autoimmune Encephalitis
Proleukin - Encephalitis
Phase 1 / Phase 2CompletedSeoul National University Hospital102016-03-012021-09-29
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
Stem cell transplantation - Encephalitis, Meningitis
Phase 1 / Phase 2CompletedVinmec Research Institute of Stem Cell and Gene Technology222014-06-162024-06-06
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection
Phase 1CompletedIchor Medical Systems Incorporated422013-12-012015-08-26
Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71
INV21 Low Dose, INV21 High Dose, Placebo - Hand, Foot and Mouth Disease
Phase 1CompletedInviragen Inc.362011-08-012015-05-06
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
WN/DEN4delta30 vaccine, Placebo - West Nile Fever
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)262008-03-012013-01-03
Phase Ib Study of SC Milatuzumab in SLE
milatuzumab, Placebo - Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Discoid
Phase 1CompletedGilead Sciences222007-01-012021-08-19
Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid
AVI-4065 Injection - Encephalitis
Phase 1CompletedSarepta Therapeutics, Inc.122006-09-012009-07-08
Phase I Study of West Nile Virus Vaccine
VRC-WNVDNA020-00-VP - West Nile Fever
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302006-03-032017-07-02
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
LGT(TP21)/DEN4, Placebo - Tick-Borne Encephalitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)282005-07-012008-01-21
Vaccine to Prevent West Nile Virus Disease
VRC-WNVDNA017-00-VP - Healthy, West Nile Fever
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)152005-03-222017-07-02
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
WN/DEN4-3'delta30, Placebo - West Nile Fever Encephalitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)562005-02-012013-01-03
A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis
Rituximab - Chronic Focal Encephalitis, Rasmussen's Encephalitis
Phase 1CompletedCalifornia Pacific Medical Center Research Institute102005-01-012013-03-22
IVIG - West Nile Encephalitis: Safety and Efficacy
Omr-lgG-am, Polygam® S/D, Placebo - West Nile Virus
Phase 1 / Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)622003-09-012011-02-07
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
Pyrimethamine, Leucovorin calcium, Zidovudine - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)262021-11-04
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
Azithromycin, Pyrimethamine, Leucovorin calcium - Toxoplasmosis, Cerebral, HIV Infections
Phase 1CompletedPfizer452008-08-26

Narrower conditions

West Nile Fever (4)  ·  Autoimmune Diseases of the Nervous System (2)  ·  Encephalomyelitis, Venezuelan Equine (2)  ·  HIV Infections (2)  ·  Toxoplasmosis (2)  ·  Toxoplasmosis, Cerebral (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Alphavirus Infections (1)  ·  Encephalitis, Japanese (1)  ·  Encephalitis, Tick-Borne (1)  ·  Encephalomyelitis, Eastern Equine (1)  ·  Encephalomyelitis, Equine (1)  ·  Encephalomyelitis, Western Equine (1)  ·  Enterovirus Infections (1)

Broader conditions

Brain Diseases (20)  ·  Central Nervous System Diseases (20)  ·  Nervous System Diseases (20)  ·  Neuroinflammatory Diseases (20)  ·  Infections (15)  ·  Central Nervous System Infections (13)  ·  RNA Virus Infections (13)  ·  Virus Diseases (12)  ·  Central Nervous System Viral Diseases (10)  ·  Arbovirus Infections (9)  ·  Encephalitis, Arbovirus (9)  ·  Encephalitis, Viral (9)  ·  Infectious Encephalitis (9)  ·  Vector Borne Diseases (9)

Interventions

Leucovorin (2)  ·  Pyrimethamine (2)  ·  Azithromycin (1)  ·  Immunoglobulins, Intravenous (1)  ·  Rituximab (1)  ·  Saline Solution (1)  ·  Stem Cell Transplantation (1)  ·  Zidovudine (1)  ·  aldesleukin (1)  ·  aluminum sulfate (1)  ·  milatuzumab (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (8)  ·  Arialys Therapeutics (2)  ·  Bavarian Nordic (1)  ·  California Pacific Medical Center Research Institute (1)  ·  Gilead Sciences (1)  ·  Ichor Medical Systems Incorporated (1)  ·  Inviragen Inc. (1)  ·  Pfizer (1)  ·  SK Bioscience Co., Ltd. (1)  ·  Sarepta Therapeutics, Inc. (1)  ·  Seoul National University Hospital (1)  ·  Vinmec Research Institute of Stem Cell and Gene Technology (1)

Countries

United States (14)  ·  Australia (3)  ·  Canada (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  Vietnam (1)

Top investigators

Anna Durbin, MD (2)  ·  Sankalp Gokhale, MD, MBA (2)  ·  Anna Durbin, M.D. (1)  ·  B Luft (1)  ·  Carlos Fierro, MD (1)  ·  Grace Chen, MD (1)  ·  Julie E Ledgerwood, DO (1)  ·  Kenneth D Laxer, M.D. (1)  ·  Liem T Nguyen (1)  ·  Luft B (1)  ·  Paul A Tambyah, MBBS (1)  ·  Paula M Shaw, MD (1)  ·  Peter Wright, MD (1)  ·  Remington J (1)  ·  William Wegener, PhD, MD (1)

Results publications

PMID 18190252, PMID 21398392, PMID 27206386, PMID 28296863, PMID 28403842, PMID 35568049, PMID 38494412